PDCD1 and gastric cardia adenocarcinoma: A recent study demonstrated that anti-PD-1 therapy triggered more hypermethylated promoters of CD274 in the secondary gastric cardia adenocarcinoma (GCA) compared to the primary GCA without anti-PD-1 therapy [178].